Frequency of retinopathy of prematurity (ROP) in infants screened for ROP: Two years follow-up results of a single center in Turkey

Review ArticleAçık Erişim

Özet

Aim: The aim of this retrospective study was to determine the incidence of retinopathy of prematurity (ROP) in infants referred to our clinic for screening ROP. Material and method: The data of 729 infants who were referred to the ROP outpatient clinic of the Ophthalmology Unit of Erzincan Binali Yildirim University, Turkey between April 2018 and March 2020 were analyzed retrospectively. The gestational age and weight of the infants, stay in the neonatal intensive care unit, duration of oxygen therapy, and detailed ophthalmologic examination findings were recorded in the study. Findings and results: Of the 729 babies screened for ROP, 122 (16.7%) of them had ROP. Infants with gestational age of ≤28 weeks constitute 3.3% of all infants and ROP rate was significantly higher than infants with older gestational age (P < 0.001). There were 39 babies born under 1000 grams and ROP was present in 28 (71.8%) of these infants and the incidence of ROP was higher than infants with higher birth weight (P < 0.001). With the result of logistic regression analysis, gestational age (OR:0.592,95% CI:0.208-0.779,P < 0.001), stay in NICU (OR:0.998,95% CI:1.022-1.421,P = 0.001), and duration of oxygen (O2) therapy (OR:34.309, 95% CI:2.043-28.235,P = 0.004) were detected the independent risk factors for ROP. Conclusion: Although infants with ≤ 1000 grams gestational weight and ≤ 28 weeks gestational age are more likely to have ROP, it is clear that screening for all infants at risk, regardless of gestational weight and age, is very important in preventing ROP-related vision loss. In addition, it is also recommended to control the duration of staying in neonatal intensive care unit and oxygen therapy to as little as needed. © the Author(s).

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/13453Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.37796/2211-8039.1188Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorUgurlu, Adem
dc.date.accessioned2026-10-18T20:28:17.115864525Z
dc.date.available2026-10-18T20:28:17.115864525Z
dc.date.issued2021
dc.description.abstractAim: The aim of this retrospective study was to determine the incidence of retinopathy of prematurity (ROP) in infants referred to our clinic for screening ROP. Material and method: The data of 729 infants who were referred to the ROP outpatient clinic of the Ophthalmology Unit of Erzincan Binali Yildirim University, Turkey between April 2018 and March 2020 were analyzed retrospectively. The gestational age and weight of the infants, stay in the neonatal intensive care unit, duration of oxygen therapy, and detailed ophthalmologic examination findings were recorded in the study. Findings and results: Of the 729 babies screened for ROP, 122 (16.7%) of them had ROP. Infants with gestational age of ≤28 weeks constitute 3.3% of all infants and ROP rate was significantly higher than infants with older gestational age (P < 0.001). There were 39 babies born under 1000 grams and ROP was present in 28 (71.8%) of these infants and the incidence of ROP was higher than infants with higher birth weight (P < 0.001). With the result of logistic regression analysis, gestational age (OR:0.592,95% CI:0.208-0.779,P < 0.001), stay in NICU (OR:0.998,95% CI:1.022-1.421,P = 0.001), and duration of oxygen (O2) therapy (OR:34.309, 95% CI:2.043-28.235,P = 0.004) were detected the independent risk factors for ROP. Conclusion: Although infants with ≤ 1000 grams gestational weight and ≤ 28 weeks gestational age are more likely to have ROP, it is clear that screening for all infants at risk, regardless of gestational weight and age, is very important in preventing ROP-related vision loss. In addition, it is also recommended to control the duration of staying in neonatal intensive care unit and oxygen therapy to as little as needed. © the Author(s).
dc.identifier.doi10.37796/2211-8039.1188
dc.identifier.eissn2211-8039
dc.identifier.endpage42
dc.identifier.issn2211-8020
dc.identifier.issue3
dc.identifier.pmcidPMC8823495
dc.identifier.pmid35223409
dc.identifier.scopus2-s2.0-85114493901
dc.identifier.startpage38
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/13453
dc.identifier.volume11
dc.identifier.wosWOS:000731463500006
dc.language.isoen
dc.publisherChina Medical University
dc.relation.ispartofBioMedicine (Taiwan)
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectFrequency
dc.subjectRetinopathy of prematurity
dc.subjectScreening
dc.subjectbilimilac
dc.subjectphenylephrine
dc.subjectproxymetacaine
dc.subjecttropamid
dc.subjecttropicamide
dc.subjectvasculotropin inhibitor
dc.subjectcontrolled study
dc.subjectcross-sectional study
dc.subjectfemale
dc.subjectfollow up
dc.subjectgestational age
dc.subjecthuman
dc.subjectinfant
dc.subjectlaser coagulation
dc.subjectmajor clinical study
dc.subjectmale
dc.subjectneonatal intensive care unit
dc.subjectoxygen therapy
dc.subjectprematurity
dc.subjectretrolental fibroplasia
dc.subjectretrospective study
dc.subjectReview
dc.subjectrisk factor
dc.subjecttreatment duration
dc.subjectTurkey (republic)
dc.titleFrequency of retinopathy of prematurity (ROP) in infants screened for ROP: Two years follow-up results of a single center in Turkey
dc.typeReview Article
dspace.entity.typePublication
rdl.citation.scopus5
rdl.citation.wos5
rdl.departmentErzincan Binali Yildirim University, Faculty of Medicine, Department of Ophthalmology, 24100, Erzincan, Turkey.
rdl.oa.statusgold
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED
rdl.wos.indexEmerging Sources Citation Index (ESCI)